| CTRI Number |
CTRI/2024/06/068838 [Registered on: 13/06/2024] Trial Registered Prospectively |
| Last Modified On: |
03/10/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Physiotherapy (Not Including YOGA) Behavioral Other (Specify) [mHealth] |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Evaluation of mobile app-supported intervention for rehabilitation care after knee replacement |
|
Scientific Title of Study
|
Evaluation of mHealth supported intervention for rehabilitation monitoring after knee replacement – An open-label randomised controlled trial |
| Trial Acronym |
Not applicable |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Niveditha Devasenapathy |
| Designation |
Lead, Better Treatments |
| Affiliation |
The George Institute for Global Health INDIA |
| Address |
Room number 308,Third Floor, Research and Development, Elegance Tower Plot No. 8, Jasola District Centre
South DELHI 110025 India |
| Phone |
|
| Fax |
|
| Email |
NDevasenapathy@georgeinstitute.org.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Niveditha Devasenapathy |
| Designation |
Lead, Better Treatments |
| Affiliation |
The George Institute for Global Health INDIA |
| Address |
308, Third Floor,
Elegance Tower Plot No. 8, Jasola District Centre
South DELHI 110025 India |
| Phone |
9810397722 |
| Fax |
|
| Email |
NDevasenapathy@georgeinstitute.org.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Niveditha Devasenapathy |
| Designation |
Lead, Better Treatments |
| Affiliation |
The George Institute for Global Health INDIA |
| Address |
308, Third Floor,
Elegance Tower Plot No. 8, Jasola District Centre
South DELHI 110025 India |
| Phone |
9810397722 |
| Fax |
|
| Email |
NDevasenapathy@georgeinstitute.org.in |
|
|
Source of Monetary or Material Support
|
| DBT/Wellcome Trust India Alliance, Nishant House, 8-2-351/N/1, 2nd floor,
Road No. 2, Venkateshwara Hills, Banjara Hills, Hyderabad - 500034 |
|
|
Primary Sponsor
|
| Name |
The George Institute for Global Health India |
| Address |
08, Third Floor, Elegance Tower Plot No. 8, Jasola District
Centre New Delhi 110025, India
|
| Type of Sponsor |
Research institution |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 2 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Sahil Batra |
All India Institute of Medical Sciences |
Room Number 733, National Centre of Ageing, AIIMS, Ansari Nagar, New Delhi -
110029 New Delhi DELHI |
01126551179
sahilbatra25@gmail.com |
| Dr Prof Rajesh Malhotra |
Indraprastha Apollo Hospital |
Room number 1212, second floor, Apollo Hospital, Sarita Vihar, Delhi-Mathura Road, New Delhi-110076 South DELHI |
91-11-71791212
rmalhotra62@yahoo.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| INSTITUTE EHTICS COMMITTEE FOR BIOMEDICAL AND HEALTH RESEARCH |
Approved |
| INSTITUTIONAL ETHICS COMMITTEE - BIOMEDICAL RESEARCH |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M170||Bilateral primary osteoarthritis of knee, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
TReAT App [TeleRehabilitation after knee ArThroplasty]
|
Intervention contains five components namely education material, videos of exercises, self-management tools using e-diary, monitoring, and consultation via a mobile application.
Patients randomised to the intervention group will be provided with the mobile application and a manual to navigate through the app. Healthcare providers will also be able to use the app and monitor patients progress remotely.
Routine clinic visits will continue as per usual practice. Physiotherapists will be able to modify patients treatment plan via the app, if required. The intervention will be available to patients for the duration of 6 months.
|
| Comparator Agent |
Usual care |
Patients randomized to usual care group will receive routine hospital care as per hospital norms. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
90.00 Year(s) |
| Gender |
Both |
| Details |
1. Adult patients (aged ≥ 18 years) scheduled for primary partial or total (unilateral or bilateral) knee arthroplasty indicated for knee arthritis.
2. Patient has access to a smartphone and internet connection
3. Patient or any of the family members living in the same household is familiar with navigating a smartphone and able to use common features such as video calling, messaging, and camera
4. Patients able to speak and read English or Hindi language
|
|
| ExclusionCriteria |
| Details |
1. Revision knee arthroplasty
2. Knee replacement indicated for trauma, tuberculosis of knee joint or other septic arthritis
3. Patients who are unable to make a hospital visit at 3 and 6 months after surgery
4. Patients who have severe cognitive impairment precluding ability to provide fully informed consent
5. Uncorrectable hearing and visual impairment
6. Not willing to be randomized to the rehabilitation approaches
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Centralized |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Patient reported knee function |
3 and 6 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| knee pain |
3 and 6 months |
| Knee range of motion |
3 and 6 months |
| Gait speed and stability |
3 and 6 months |
| Balance |
3 and 6 months |
| Lower limb strength |
3 and 6 months |
| Lower extremity activity level |
3 and 6 months |
| Safety (number of falls) |
3 and 6 months |
| Patient experience |
6 months |
| Cost effect and utility |
3 months |
|
|
Target Sample Size
|
Total Sample Size="300" Sample Size from India="300"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3/ Phase 4 |
|
Date of First Enrollment (India)
|
24/06/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="8" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
Monitoring of Physical rehabilitation is an essential component of patient recovery after knee arthroplasty. Monitoring can be remote or clinic-based. In India, unsupervised home-based physical rehabilitation is a common practice, and there is lack of evidence to demonstrate effectiveness of remote monitoring of rehabilitation. Therefore, we developed and piloted a mobile application [Tele REhabilitation after knee ArThroplasty (TReAT app)] based on behavior design-design thinking approach to support the recovery period. The TReAT app consists of five components: knowledge, skills, self-management & motivation, communication with healthcare providers, and monitoring by healthcare providers. We aim to compare the effectiveness, acceptability, cost, and safety of this app-based intervention against usual care (home-based with various levels of in-person supervision in clinic) using open label, 1:1 individual randomized superiority trial at two tertiary care hospitals in Delhi. The primary objective would be to compare patient reported knee function between the two groups at 3- and 6-months post-surgery. Additionally, we will also compare patient reported outcomes (pain, falls), performance-based outcomes (lower limb strength and function), knowledge about recovery, rehabilitation adherence, satisfaction with surgery, resource utilization and cost, quality of life. End user experience and fidelity of the implementation will be measured using both quantitative and qualitative methods. Consecutive adult patients undergoing partial or total (unilateral or bilateral) knee arthroplasty at each of the hospitals (one unit) will be screened for eligibility. Consenting individuals will be randomized to either app-supported intervention or usual care group. The target sample size is 300 patients, to be recruited over a period of one year. Data will be collected at baseline, 3 months, and 6 months post-surgery by a trained research coordinator. Anonymous quantitative data will be entered and stored in a web-based electronic data capture system. Qualitative data will be stored securely in password protected folders and data will be anonymized before analysis to maintain patient confidentiality. Quantitative data will be analysed in Stata17, and group comparisons will be done using mixed effect linear regression. Qualitative data will be analyzed via an inductive-deductive approach using NVivo software. The trial is funded by DBT-Wellcome trust India alliance and trial will be initiated after obtaining ethical approvals from The George Institute for global health (Sponsor), India, All India Institute of Medical Sciences, Delhi and Indraprastha Apollo Hospital, Delhi. All ethical guidelines will be followed related to voluntary informed consent and data confidentiality laid by ICMR for conduct of research on human participants. The trial will be insured, and any trial related harm will be compensated. Participants will be provided monetary compensation for trial specific hospital visits as per institutional norms and ethical guidelines. This intervention can be incorporated into routine clinical practice for remote supervision of home-based rehabilitation given it is proven to be clinically effective, safe, cost effective and accepted by the end users. This would serve the aim of improving patient experience and aid in faster recovery post knee arthroplasty. |